Neurological Biomarkers

A Global Strategic Business Report

MCP32324

RESEARCH DASHBOARD

OCT 2025

RELEASE DATE

7147

EXECUTIVE POOL

5850

PRICE

816

EXPERT INPUTS

41

COMPANIES

318

DATA TABLES

389

PAGES

2

EDITION

WHAT'S BEHIND OUR DATA?

140857226

DOMAIN TRANSCRIPTS

6080276

BRANDS TRACKED

1729341

FEATURED COMPANIES

22574

TOPICS COVERED

82719

MARKET SEGMENTS

91

KEY INDUSTRIES

1574

CURATION TEAM

4761909

DECISION MAKERS

EXECUTIVE ENGAGEMENTS BY TIER (55)

3

CXO

5

VICE PRESIDENT

10

DIRECTOR

25

MANAGER

12

MARKETING

REQUEST FULL-STACK INDEX Includes 350+ pages validated sources

QUESTIONNAIRE EXECUTIVES DATA ROOM

OUR EXPERT PANELS

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

INFLUENCER INVITEE

WHY PARTICIPATE?

Expertise to the Power of YOU!

Collaborative Insights - Expand your deep domain insights from participants at competitive companies worldwide while you share your own!
Global Acumen Alerts - Expand your intelligence on your areas of interest by enabling our “Email Alerts” feature drawing from other influencers’ project participation.
Enterprise-wide Project Discounts - Discounts start @ 10% and build up as more participants support our ongoing projects in your space.
Complimentary Copies - We highly recommend collaboration with your team to draw upon their geographical domain expertise. Our platform enables collaborative engagements with 10 peers. When you or any of your team members purchase the report, the entire team will receive complimentary copies with full stack access to our data and updates for one year.
Annual Digital Subscription to one of the business publications or $100 value gift card - No Purchase Required! The lead participant will receive the digital subscription

The Economist
MIT Technology Review
Harvard Business Review

Note - Offer is limited to one participant per company. Offer may be withdrawn at anytime without notice once our annual maximum participation of leading players is fulfilled. Offer by invitation only, to enterprise executives in from companies featured in the project ranked. If you’ve received our initation, you’re qualified! If not, you may check your eligibility by registering to join our Project Expert Panel. Typically you must be have a Marketing, Strategy, Product Management or Business Development, role as a CXO or VP or Director or Manager directly involved with the P&L of the products or services covered in the report. You must complete all modules in the Primary Research Data Simulator.

MARKETGLASS

BASIC

Annual Prepaid Subscription
Single-User
10,000 Data Room Credits/Month
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use MarketGlass^TM Data Templates For Your Own Enterprise Data to Build Bespoke Research Reports.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.

PREMIUM

Annual Prepaid Subscription
One Research Project With One Complimentary Update/Year
10-User License
10-User Peer-to-Peer Collaborative Features
200 Domain Expert Insights (With Name, Company, and Date)
50,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

ENTERPRISE

Annual Prepaid Subscription
Four Research Projects With One Complimentary Update/Year
25-User License
25-User Peer-to-Peer Collaborative Engagements
500 Domain Expert Insights (With Name, Company, and Date)
150,000 Data Room Credits
Research Tool - Unlimited Access to Build Your Own Search Engine Data & Domain Expert Video Transcriptions.
Use Publisher's Market Data Templates to Simulate & Build Your Bespoke Variations to Published Data (4 Reports/Year)
Use Your Own Data and MarketGlass^TM Data Room Content.
My Silo - Build Your Private Data Room for Generative AI and Other Applications. Download Data Stacks For External Applications & Language Models.
Add Extra Topics/Reports During The Year At Regular Prices With Full Platform Privileges

HIGHLIGHTS & REPORT INDEX

Global Neurological Biomarkers Market to Reach US$17.1 Billion by 2030

The global market for Neurological Biomarkers estimated at US$8.8 Billion in the year 2024, is expected to reach US$17.1 Billion by 2030, growing at a CAGR of 11.7% over the analysis period 2024-2030. Genomic Biomarkers, one of the segments analyzed in the report, is expected to record a 9.9% CAGR and reach US$7.5 Billion by the end of the analysis period. Growth in the Proteomic Biomarkers segment is estimated at 14.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$2.4 Billion While China is Forecast to Grow at 15.5% CAGR

The Neurological Biomarkers market in the U.S. is estimated at US$2.4 Billion in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$3.5 Billion by the year 2030 trailing a CAGR of 15.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.7% and 10.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.2% CAGR.

Global Neurological Biomarkers Market – Key Trends & Drivers Summarized

Why Are Neurological Biomarkers Reshaping the Diagnosis and Treatment of Brain Disorders?

Neurological biomarkers have emerged as critical tools for diagnosing, monitoring, and treating various neurological disorders, ranging from Alzheimer’s disease and Parkinson’s disease to traumatic brain injuries and multiple sclerosis. These biomarkers, which include genetic, proteomic, metabolomic, and imaging-based indicators, provide valuable insights into the pathophysiology of brain diseases, allowing for earlier and more accurate diagnoses. Unlike traditional diagnostic approaches that often rely on subjective clinical observations, neurological biomarkers offer objective, quantifiable data that enhance precision medicine initiatives. The use of cerebrospinal fluid (CSF) and blood-based biomarkers is gaining traction, enabling non-invasive and minimally invasive diagnostic methods that improve patient compliance. Additionally, advancements in neuroimaging, such as positron emission tomography (PET) and functional MRI (fMRI), have expanded biomarker research, allowing clinicians to track disease progression in real-time. The growing integration of artificial intelligence (AI) in biomarker analysis is further revolutionizing the field, making it possible to detect subtle disease-related changes that might go unnoticed through conventional methods. As demand for early detection and personalized treatment strategies increases, the neurological biomarkers market is becoming a cornerstone of modern neurology, significantly improving patient outcomes and treatment efficacy.

What Challenges Are Hindering the Widespread Adoption of Neurological Biomarkers?

Despite their potential, neurological biomarkers face several challenges that impact their clinical adoption and widespread use. One of the major obstacles is the complexity of neurological disorders, as many conditions have overlapping symptoms and multifactorial causes, making it difficult to develop highly specific and reliable biomarkers. Additionally, the high cost and technical expertise required for biomarker validation and standardization pose significant barriers, particularly in resource-limited healthcare settings. Variability in biomarker measurements across different patient populations and laboratory settings further complicates their clinical implementation, leading to concerns about reproducibility and regulatory approval. Another challenge is the need for larger, well-controlled clinical studies to establish the predictive and diagnostic value of emerging biomarkers. The slow pace of regulatory approvals for biomarker-based diagnostic tests also delays market entry, restricting the availability of cutting-edge diagnostic tools. Furthermore, patient accessibility remains an issue, as biomarker testing is not yet widely covered by insurance providers in many countries. Addressing these challenges requires greater collaboration between researchers, regulatory bodies, and healthcare providers to develop standardized, cost-effective, and clinically validated neurological biomarker solutions.

How Are Technological Innovations Transforming Neurological Biomarker Research?

The field of neurological biomarkers is undergoing a technological revolution, with innovations in genomics, proteomics, and bioinformatics accelerating the discovery and application of novel biomarkers. One of the most promising advancements is the development of liquid biopsy techniques, which allow for the detection of neurological biomarkers in blood, saliva, or urine, providing a non-invasive alternative to traditional CSF-based testing. AI and machine learning algorithms are also playing a critical role in biomarker discovery and analysis, enabling the identification of complex biomarker patterns associated with neurodegenerative diseases. The integration of multi-omics approaches, which combine genomic, transcriptomic, proteomic, and metabolomic data, is further enhancing biomarker research, providing a more comprehensive understanding of disease mechanisms. Additionally, wearable neurotechnology and digital biomarkers are gaining momentum, allowing continuous monitoring of neurological function in real-world settings. These advancements are not only improving early detection and disease monitoring but also paving the way for precision medicine approaches that tailor treatments based on an individual’s unique biomarker profile. As the industry continues to embrace cutting-edge technologies, the role of neurological biomarkers in shaping the future of neurology is becoming increasingly significant.

What Is Driving the Growth of the Neurological Biomarkers Market?

The growth in the neurological biomarkers market is driven by several factors, including the rising prevalence of neurodegenerative diseases, increasing demand for personalized medicine, and advancements in biomarker detection technologies. The global surge in Alzheimer’s disease, Parkinson’s disease, and other age-related neurological disorders is fueling the need for early diagnostic tools, accelerating biomarker research and development. The expansion of clinical trials focused on neurological diseases is also contributing to market growth, as pharmaceutical companies invest in biomarker-based drug development strategies to improve therapeutic outcomes. Additionally, regulatory support for biomarker-driven diagnostics is increasing, with agencies such as the FDA and EMA encouraging the integration of biomarkers into clinical trials and precision medicine programs. The growing adoption of digital biomarkers and remote monitoring solutions is further expanding market opportunities, enabling real-time tracking of cognitive and motor functions. Increased funding from government and private organizations is also supporting biomarker discovery efforts, fostering collaborations between academia, biotech firms, and healthcare providers. As technological innovations continue to enhance the accuracy, accessibility, and clinical utility of neurological biomarkers, the market is poised for significant expansion, driving the next wave of advancements in neurology and precision diagnostics.

SCOPE OF STUDY

The report analyzes the Neurological Biomarkers market by the following Segments, and Geographic Regions/Countries:

Segments:

Biomarkers Type (Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers, Other Biomarkers); Application (Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis, Autism Spectrum Disorder, Other Applications); End-Use (Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use, Other End-Uses).

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa..

SELECT PLAYERS

Abcam plc; Agilent Technologies, Inc.; Beckman Coulter Diagnostics; BioNTech SE; Bio-Rad Laboratories, Inc.; Charles River Laboratories International, Inc.; F. Hoffmann-La Roche Ltd; Fujirebio; GE Healthcare; Illumina, Inc.; IXICO plc; Johnson & Johnson Services, Inc.; Merck KGaA; Myriad Genetics, Inc.; Pacific Biomarkers; PerkinElmer, Inc.; Proteome Sciences plc; Qiagen N.V.; Siemens Healthineers AG; Thermo Fisher Scientific Inc.;

AI INTEGRATIONS

We’re transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy

How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind

Neurological Biomarkers – Global Key Competitors Percentage Market Share in 2025 (E)

Competitive Market Presence - Strong/Active/Niche/Trivial for 41 Players Worldwide in 2025 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

Rising Prevalence of Neurodegenerative Diseases Propels Demand for Advanced Biomarker-Based Diagnostics

Increasing Global Burden of Alzheimer's and Parkinson's Disease Expands Addressable Market Opportunity

Growing Preference for Personalized Medicine Strengthens Business Case for Neurological Biomarkers

Surging R&D Investments in CNS Disorders Drives Innovation and Biomarker Discovery

Advances in Liquid Biopsy Technologies Accelerate Demand for Non-Invasive Neurological Biomarkers

Increased Adoption of Digital Biomarkers and AI-Enabled Diagnostics Drives Market Expansion

Integration of Multi-Omics Platforms Spurs Development of High-Specificity Biomarker Panels

Growing Regulatory Focus on Early Disease Detection Throws the Spotlight on Biomarker Validation

Emergence of Point-of-Care Neurological Tests Drives Accessibility and Market Penetration

Rising Clinical Trials for CNS Therapies Generate Demand for Companion Diagnostic Biomarkers

Expansion of Neurology-Focused Biobanks Strengthens Research Infrastructure and Commercialization Potential

Collaborations Between Pharma and Diagnostic Companies Drive Co-Development of Biomarker Solutions

Favorable Reimbursement Policies in Developed Markets Sustain Growth in Clinical Adoption

Rising Health Awareness and Early Screening Initiatives Accelerate Demand in Emerging Markets

Shift Toward Preventive Healthcare Models Expands Market for Predictive Neurological Biomarkers

Growing Use of Biomarkers in Drug Development Pipelines Drives Pharmaceutical Adoption

FDA and EMA Fast-Tracking Biomarker Qualification Processes Spurs Industry Confidence and Investment

Advances in Neuroimaging Integration with Biomarker Data Drive Adoption of Hybrid Diagnostic Platforms

Increasing Utilization of Wearable Devices Throws the Spotlight on Real-Time Digital Biomarkers

Challenges in Standardization and Validation Pose Barriers to Widespread Clinical Adoption

Growing Geriatric Population Globally Drives Long-Term Demand for Neurological Diagnostics

Rising Incidence of Traumatic Brain Injuries and Stroke Fuels Demand for Rapid Biomarker Tests

Expansion of Telehealth and Remote Monitoring Platforms Drives Need for Scalable Biomarker Solutions

Growing Academic-Industry Collaborations Propel Translational Research and Commercial Viability

4. GLOBAL MARKET PERSPECTIVE

World Neurological Biomarkers Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030

World Recent Past, Current & Future Analysis for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Neurological Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Genomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Genomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Genomic Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Proteomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Proteomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Proteomic Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Metabolomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Metabolomic Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Metabolomic Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Imaging Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Imaging Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Imaging Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Biomarkers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Alzheimer`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Alzheimer`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Alzheimer`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Parkinson`s Disease by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Parkinson`s Disease by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Multiple Sclerosis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Multiple Sclerosis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Autism Spectrum Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Autism Spectrum Disorder by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Autism Spectrum Disorder by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Hospital & Hospital Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Hospital & Hospital Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Hospital & Hospital Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Independent Clinical Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Independent Clinical Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Independent Clinical Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Research Organizations End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Research Organizations End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

UNITED STATES

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)

USA Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

USA Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

USA Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

USA 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

CANADA

Canada Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Canada Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Canada Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Canada 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

JAPAN

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)

Japan Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Japan Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Japan Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Japan 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

CHINA

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)

China Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

China Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

China Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

China 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

EUROPE

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)

Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Europe Historic Review for Neurological Biomarkers by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Europe Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Europe 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

FRANCE

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)

France Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

France Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

France Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

France 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

GERMANY

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)

Germany Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Germany Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Germany Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Germany 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

ITALY

Italy Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Italy Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Italy Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Italy 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

UNITED KINGDOM

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)

UK Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

UK Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UK Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UK 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

SPAIN

Spain Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Spain Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Spain Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Spain 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

RUSSIA

Russia Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Russia Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Russia Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Russia 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

REST OF EUROPE

Rest of Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Rest of Europe Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Europe Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Europe 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

ASIA-PACIFIC

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)

Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Neurological Biomarkers by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Asia-Pacific Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Asia-Pacific 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

AUSTRALIA

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)

Australia Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Australia Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Australia Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Australia 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

INDIA

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)

India Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

India Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

India Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

India 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

SOUTH KOREA

South Korea Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

South Korea Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

South Korea Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

South Korea 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

REST OF ASIA-PACIFIC

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Asia-Pacific Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Asia-Pacific 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

LATIN AMERICA

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)

Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Latin America Historic Review for Neurological Biomarkers by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Latin America Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Latin America 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

ARGENTINA

Argentina Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Argentina Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Argentina Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Argentina 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

BRAZIL

Brazil Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Brazil Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Brazil Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Brazil 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

MEXICO

Mexico Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Mexico Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Mexico Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Mexico 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

REST OF LATIN AMERICA

Rest of Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Rest of Latin America Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Latin America Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Latin America 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

MIDDLE EAST

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)

Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR

Middle East Historic Review for Neurological Biomarkers by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Neurological Biomarkers by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Middle East Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Middle East 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

IRAN

Iran Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Iran Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Iran Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Iran 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

ISRAEL

Israel Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Israel Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Israel Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Israel 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

SAUDI ARABIA

Saudi Arabia Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Saudi Arabia Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Saudi Arabia Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Saudi Arabia 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

UNITED ARAB EMIRATES

UAE Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

UAE Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

UAE Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

UAE 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

REST OF MIDDLE EAST

Rest of Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Rest of Middle East Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Rest of Middle East Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Rest of Middle East 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

AFRICA

Neurological Biomarkers Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)

Africa Recent Past, Current & Future Analysis for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Neurological Biomarkers by Biomarkers Type - Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Neurological Biomarkers by Biomarkers Type - Percentage Breakdown of Value Sales for Genomic Biomarkers, Proteomic Biomarkers, Metabolomic Biomarkers, Imaging Biomarkers and Other Biomarkers for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Neurological Biomarkers by Application - Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Neurological Biomarkers by Application - Percentage Breakdown of Value Sales for Other Applications, Alzheimer`s Disease, Parkinson`s Disease, Multiple Sclerosis and Autism Spectrum Disorder for the Years 2015, 2025 & 2030

Africa Recent Past, Current & Future Analysis for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR

Africa Historic Review for Neurological Biomarkers by End-Use - Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR

Africa 15-Year Perspective for Neurological Biomarkers by End-Use - Percentage Breakdown of Value Sales for Hospital & Hospital Laboratories End-Use, Independent Clinical Diagnostic Centers End-Use, Research Organizations End-Use and Other End-Uses for the Years 2015, 2025 & 2030

COMPETITIVE METRICS

COMPETITORS (ALPHABETICAL)	% VALIDATED RESEARCH *

* Login to Participate & View Data Stacks

* Participating executives must be from a competitive company. Executive credentials are validated by a one-time two-factor authentication, in compliance with GDPR guidelines. Verified executives have complimentary access to our proprietary MarketGlass^TM platform and relevant data silos including Trend Data; Brand/IP/TM Feeds; and Market Size, Share & Rank Clusters. Qualified influencers are also invited to join our Expert Panels. Privileges include purchase credits, and collaborative bespoke builds.

View All Companies...

PARTICIPATE NOW!

PREVIEW REPORT

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]

DIFFERENTIATORS

Integrity Trust Transparency

Our research offerings primarily draw upon unique perspectives of participating executives and their experiences in operating and strategy roles. These geo-focused insights enrich our projects .

What we are NOT - Our reports are not editorial exercises of remote analysts’ secondary source fed content that predominantly flood today’s off-the-shelf market report business. (A review of 262 publishers).

WHAT SETS US APART

FULL STACK DATA ACCESS

Primary Research Cluster Data
Influencer Engagement Stats
Evidence of Primary Research
List of Companies Engaged
Hundreds of Pages of Research
Peer Collaborative Interactions
Enterprise Data Exchanges
MarketGlassTM Platform Insider
Geographic Pricing Dynamics
Competitive Shares by Country
Brand Curation & Insights
Domain Expert Pool

Program Transparency: Clients have access to engagement stats of companies and executives. Clients may commission third-party audits of our influencer engagements at their expense.

Primary Research: We have a very successful incentive driven primary research program presenting a rich experience to participating executives. Featured company executives can sign up for a complimentary.

Collaborative Intelligence: Our platform presents a unique features for executives to collaborate with peers across geographies and participate on various product or regional perspectives for a collective unified insider project experience.

Global Brand Intelligence: We present competitive brand intelligence at the company level for players worldwide. Executives from brand owner companies participate to curate each brand for relevance and market presence.

Bespoke Updates: Our peer-to-peer online interactive platform enables client companies to build upon our project data stacks to build bespoke editions for internal sharing and use. Client company can build one complimentary update per year and unlimited updates for additional fee. Bespoke updates are fulfilled within a two-day turnaround.

Enterprise EcoConnect: Discretely bounce off queries to participant pool of executives. We can reach out to our participant pool based on specifics of geographic or domain acumen.

Renowned Support: We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Complimentary Updates: Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

No Fluff: We offer our clients the best CX with clean easy to read content. No verbose fluff. We offer clients full access to the entire stack of hundreds of pages of secondary research feeds used in our project via our online MarketGlass portal.

Scroll